SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Lantibio Inc. and TRB Chemedica Announce Licensing Agreement with Alcon Laboratories, Inc. for US Development and Marketing of Dry Eye Drug